Ultragenyx Pharmaceutical | RARE - Прибыль до налогообложения

Биржевая цена
21.25
Изменение за день
-0.21 -0.98%
Ежемесячно
-11.01%
Ежегодный
-44.98%
Q1 прогноз
22.67




Прибыль до налогообложения Изменить Дата
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
BioCryst Pharmaceuticals USD -86.95M 73.5M 2024-12
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Immunic USD -21.38M 8.2M 2024-06
Insmed USD -326.93M 41.77M 2025-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
Kyowa Hakko Kirin JPY 39.3B 13.35B 2025-12
MacroGenics USD 16.82M 52.97M 2025-09
Moderna USD -187M 631M 2025-09
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Xoma USD 15.98M 24.58M 2024-06